{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:50:09Z","timestamp":1792036209699,"version":"4.4.0"},"reference-count":61,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gonadotoxicity resulting from systemic and locoregional cancer treatments significantly threatens women\u2019s reproductive health, often culminating in premature ovarian insufficiency. These therapies, particularly alkylating agents and ionizing radiation, induce DNA damage and apoptosis in ovarian follicles, leading to infertility, amenorrhea, and estrogen deficiency, which exacerbate risks of osteoporosis and cardiovascular diseases. Existing fertility preservation methods do not prevent immediate ovarian damage, underscoring the need for innovative protective strategies. Menstrual blood-derived stem cells (MenSC) and their extracellular vesicles (EV) present promising regenerative potential due to their therapeutic cargo delivery and pathway modulation capabilities. Preclinical studies demonstrate that MenSC-derived EV ameliorate premature ovarian insufficiency by inhibiting granulosa cell apoptosis, promoting angiogenesis, and activating pivotal pathways such as SMAD3\/AKT\/MDM2\/P53. However, comprehensive research is imperative to ensure the safety, efficacy, and long-term effects of MenSC-derived EV in clinical practice. In this review, we update the current knowledge and research regarding the use of MenSC-derived EV as a novel therapeutic weapon for ovarian regeneration in the context of gonadotoxicity induced by systemic anticancer treatment.<\/jats:p>","DOI":"10.3390\/ijms25158468","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T16:14:58Z","timestamp":1722615298000},"page":"8468","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Menstrual Blood Stem Cells-Derived Exosomes as Promising Therapeutic Tools in Premature Ovarian Insufficiency Induced by Gonadotoxic Systemic Anticancer Treatment"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1442-1936","authenticated-orcid":false,"given":"Mariana","family":"Robalo Cordeiro","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Gynecology University Clinic, University of Coimbra, 3000-548 Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-2506","authenticated-orcid":false,"given":"Ricardo","family":"Roque","sequence":"additional","affiliation":[{"name":"Portuguese Institute of Oncology of Coimbra, Medical Oncology Department, 3000-075 Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-3643","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Laranjeiro","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Gynecology University Clinic, University of Coimbra, 3000-548 Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Carvalhos","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Gynecology University Clinic, University of Coimbra, 3000-548 Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8396-2667","authenticated-orcid":false,"given":"Margarida","family":"Figueiredo-Dias","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Gynecology University Clinic, University of Coimbra, 3000-548 Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"hoad024","DOI":"10.1093\/hropen\/hoad024","article-title":"Ovarian reserve in reproductive-aged patients with cancer before gonadotoxic treatment: A systematic review and meta-analysis","volume":"2023","author":"Wu","year":"2023","journal-title":"Hum. Reprod. Open"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Karavani, G., Rottenstreich, A., Schachter-Safrai, N., Cohen, A., Weintraub, M., Imbar, T., and Revel, A. (2021). Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation. BMC Womens Health, 21.","DOI":"10.1186\/s12905-021-01343-z"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: Mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Han, Y., Li, X., Zhang, Y., Han, Y., Chang, F., and Ding, J. (2019). Mesenchymal stem cells for regenerative medicine. Cells, 8.","DOI":"10.3390\/cells8080886"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bozorgmehr, M., Gurung, S., Darzi, S., Nikoo, S., Kazemnejad, S., Zarnani, A.H., and Gargett, C.E. (2020). Endometrial and Menstrual Blood Mesenchymal Stem\/Stromal Cells: Biological Properties and Clinical Application. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00497"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","article-title":"Extracellular vesicles and nanoparticles: Emerging complexities","volume":"33","author":"Jeppesen","year":"2023","journal-title":"Trends Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13287-023-03413-5","article-title":"Menstrual blood-derived mesenchymal stromal cells: Impact of preconditioning on the cargo of extracellular vesicles as potential therapeutics","volume":"14","author":"Pulido","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s13287-023-03551-w","article-title":"Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency","volume":"14","author":"Zhang","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/humrep\/deu158","article-title":"Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: A 12-year retrospective analysis","volume":"29","author":"Imbert","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0303-7207(00)00365-8","article-title":"Reproduction post-chemotherapy in young cancer patients","volume":"169","author":"Meirow","year":"2000","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2011.10.014","article-title":"Ovarian response to stimulation for fertility preservation in women with malignant disease: A systematic review and meta-analysis","volume":"97","author":"Friedler","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility Preservation in Patients with Cancer: ASCO Clinical Practice Guideline Update","volume":"36","author":"Oktay","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","article-title":"Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss","volume":"115","author":"Shai","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum. Reprod. Update"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, Z., Qi, H., Li, Z., Bao, Y., Yang, K., and Min, Q. (2023). Research progress on the premature ovarian failure caused by cisplatin therapy. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1276310"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wu, C., Wu, T., Chen, D., Wei, S., Tang, W., Xue, L., Xiong, J., Huang, Y., Guo, Y., and Chen, Y. (2022). The effects and mechanism of taxanes on chemotherapy-associated ovarian damage: A review of current evidence. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1025018"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10549-014-2914-x","article-title":"What lies behind chemotherapy-induced amenorrhea for breast cancer patients: A meta-analysis","volume":"145","author":"Zhao","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4048\/jbc.2019.22.e53","article-title":"Amenorrhea and menopause in patients with breast cancer after chemotherapy","volume":"22","author":"Shin","year":"2019","journal-title":"J. Breast Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fertnstert.2016.10.020","article-title":"Impact of tamoxifen therapy on fertility in breast cancer survivors","volume":"107","author":"Shandley","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Himpe, J., Lammerant, S., Van den Bergh, L., Lapeire, L., and De Roo, C. (2023). The Impact of Systemic Oncological Treatments on the Fertility of Adolescents and Young Adults\u2014A Systematic Review. Life, 13.","DOI":"10.3390\/life13051209"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-021-06267-8","article-title":"Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)","volume":"189","author":"Ruddy","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.6004\/jnccn.2022.7065","article-title":"Impact of Anti-HER2 Therapy Alone and with Weekly Paclitaxel on the Ovarian Reserve of Young Women with HER2-Positive Breast Cancer","volume":"21","author":"Lambertini","year":"2023","journal-title":"JNCCN J. Natl. Compr. Cancer Netw."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jnci\/djy094","article-title":"Adjuvant Anti-HER2 Therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients","volume":"111","author":"Lambertini","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3892\/mco.2017.1237","article-title":"Ovarian function following targeted anti-angiogenic therapy with bevacizumab","volume":"6","author":"Imai","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ishizuka, B. (2021). Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI). Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.626924"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chon, S.J., Umair, Z., and Yoon, M.S. (2021). Premature Ovarian Insufficiency: Past, Present, and Future. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.672890"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"j5101","DOI":"10.1136\/bmj.j5101","article-title":"Non-hormonal treatments for menopausal symptoms","volume":"359","author":"Hickey","year":"2017","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Piasecka-Srader, J., Blanco, F.F., Delman, D.H., Dixon, D.A., Geiser, J.L., Ciereszko, R.E., and Petroff, B.K. (2015). Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries. Biol. Reprod., 92.","DOI":"10.1095\/biolreprod.114.126136"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e13087","DOI":"10.1111\/jne.13087","article-title":"Development of the gonadotropin-releasing hormone system","volume":"34","author":"Duittoz","year":"2022","journal-title":"J. Neuroendocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaoncol.2015.3251","article-title":"Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: A systematic review and meta-analysis","volume":"2","author":"Munhoz","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1302\/2058-5241.6.200017","article-title":"Platelet-rich plasma: A narrative review","volume":"64","author":"Collins","year":"2021","journal-title":"EFORT Open Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/15376516.2018.1491662","article-title":"Effect of platelet-rich plasma (PRP) on ovarian structures in cyclophosphamide-induced ovarian failure in female rats: A stereological study","volume":"28","author":"Dehghani","year":"2018","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1007\/s43032-023-01300-1","article-title":"Potential Therapeutic Options for Premature Ovarian Insufficiency: Experimental and Clinical Evidence","volume":"30","author":"Ding","year":"2023","journal-title":"Reprod. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0041-1741451","article-title":"Protective Effects of Platelet-rich plasma for in vitro Fertilization of Rats with Ovarian Failure Induced by Cyclophosphamide","volume":"44","author":"Budak","year":"2022","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/biolre\/ioz077","article-title":"G-CSF-mobilized peripheral blood mononuclear cells combined with platelet-rich plasma accelerate restoration of ovarian function in cyclophosphamide-induced POI rats","volume":"101","author":"Huang","year":"2019","journal-title":"Biol. Reprod."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000345615","article-title":"Introduction to stem cells and regenerative medicine","volume":"85","author":"Kolios","year":"2012","journal-title":"Respiration"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13287-019-1315-9","article-title":"Human amniotic mesenchymal stem cells improve the follicular microenvironment to recover ovarian function in premature ovarian failure mice","volume":"10","author":"Liu","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mohamed, S.A., Shalaby, S., Brakta, S., Elam, L., Elsharoud, A., and Al-Hendy, A. (2019). Umbilical cord blood mesenchymal stem cells as an infertility treatment for chemotherapy induced premature ovarian insufficiency. Biomedicines, 7.","DOI":"10.3390\/biomedicines7010007"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dew041","article-title":"Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency","volume":"31","author":"Su","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41374-019-0321-y","article-title":"Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN","volume":"100","author":"Yang","year":"2020","journal-title":"Lab. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tice.2018.09.010","article-title":"A feasible method for the isolation of mesenchymal stem cells from menstrual blood and their exosomes","volume":"55","author":"Dalirfardouei","year":"2018","journal-title":"Tissue Cell."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Matsuzaka, Y., and Yashiro, R. (2022). Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126480"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13287-021-02511-6","article-title":"Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine","volume":"12","author":"Chen","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13287-016-0453-6","article-title":"Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure","volume":"8","author":"Chen","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: Key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Xiao, S., Du, J., Yuan, G., Luo, X., and Song, L. (2024). Granulosa Cells-Related MicroRNAs in Ovarian Diseases: Mechanism, Facts and Perspectives. Reprod. Sci.","DOI":"10.1007\/s43032-024-01523-w"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7132708","DOI":"10.1155\/2019\/7132708","article-title":"MSC-Derived Exosome Promotes M2 Polarization and Enhances Cutaneous Wound Healing","volume":"2019","author":"He","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12943-021-01376-w","article-title":"The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells","volume":"20","author":"Hosseini","year":"2021","journal-title":"Mol. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41417-022-00427-8","article-title":"Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy","volume":"29","author":"Sohrabi","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Song, A., Zhang, S., Zhao, X., Wu, S., Qi, X., Gao, S., Qi, J., Li, P., and Tan, J. (2023). Exosomes derived from menstrual blood stromal cells ameliorated premature ovarian insufficiency and granulosa cell apoptosis by regulating SMAD3\/AKT\/MDM2\/P53 pathway via delivery of thrombospondin-1. Biomed. Pharmacother., 166.","DOI":"10.1016\/j.biopha.2023.115319"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13287-021-02255-3","article-title":"Concentrated exosomes from menstrual blood-derived stromal cells improves ovarian activity in a rat model of premature ovarian insufficiency","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13287-023-03339-y","article-title":"PDGFBB improved the biological function of menstrual blood-derived stromal cells and the anti-fibrotic properties of exosomes","volume":"14","author":"Zhang","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Qi, J., Zhang, X., Zhang, S., Wu, S., Lu, Y., Li, S., Li, P., and Tan, J. (2023). P65 mediated UBR4 in exosomes derived from menstrual blood stromal cells to reduce endometrial fibrosis by regulating YAP Ubiquitination. J. Nanobiotechnol., 21.","DOI":"10.1186\/s12951-023-02070-3"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00441-023-03820-3","article-title":"The function of exosomes in ovarian granulosa cells","volume":"394","author":"Zhou","year":"2023","journal-title":"Cell Tissue Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e2859","DOI":"10.7717\/peerj.2859","article-title":"miR-21 increases c-kit++ cardiac stem cell proliferation in vitro through PTEN\/PI3K\/Akt signaling","volume":"5","author":"Shi","year":"2017","journal-title":"PeerJ"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13287-021-02138-7","article-title":"Advances in mesenchymal stem cell exosomes: A review","volume":"12","author":"Tang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-4939-7253-1_32","article-title":"Isolation of Extracellular Vesicles from Stem Cells","volume":"1660","author":"Chen","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"103197","DOI":"10.1016\/j.xpro.2024.103197","article-title":"Protocol for isolating and identifying small extracellular vesicles derived from human umbilical cord mesenchymal stem cells","volume":"5","author":"Chen","year":"2024","journal-title":"STAR Protoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8468\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:29:17Z","timestamp":1760110157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":61,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25158468"],"URL":"https:\/\/doi.org\/10.3390\/ijms25158468","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}